Eric Fink - Net Worth and Insider Trading

Eric Fink Net Worth

The estimated net worth of Eric Fink is at least $353,477 dollars as of 2024-11-09. Eric Fink is the Chief Human Resources Officer of Global Blood Therapeutics Inc and owns about 5,161 shares of Global Blood Therapeutics Inc (GBT) stock worth over $353,477. Details can be seen in Eric Fink's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Fink has not made any transactions after 2021-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Eric Fink

To

Eric Fink Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric Fink owns 1 companies in total, including Global Blood Therapeutics Inc (GBT) .

Click here to see the complete history of Eric Fink’s form 4 insider trades.

Insider Ownership Summary of Eric Fink

Ticker Comapny Transaction Date Type of Owner
GBT Global Blood Therapeutics Inc 2021-05-10 Chief Human Resources Officer

Eric Fink Latest Holdings Summary

Eric Fink currently owns a total of 1 stock. Eric Fink owns 5,161 shares of Global Blood Therapeutics Inc (GBT) as of May 10, 2021, with a value of $353,477.

Latest Holdings of Eric Fink

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GBT Global Blood Therapeutics Inc 2021-05-10 5,161 68.49 353,477

Holding Weightings of Eric Fink


Eric Fink Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric Fink has made a total of 3 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Global Blood Therapeutics Inc is the acquisition of 500 shares on May 10, 2021, which cost Eric Fink around $18,980.

Insider Trading History of Eric Fink

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric Fink Trading Performance

GuruFocus tracks the stock performance after each of Eric Fink's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Fink is -17.03%. GuruFocus also compares Eric Fink's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Fink within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eric Fink's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eric Fink

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.21 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 10 LIMIT LIMIT LIMIT LIMIT LIMIT

Eric Fink Ownership Network

Ownership Network List of Eric Fink

No Data

Ownership Network Relation of Eric Fink

Insider Network Chart

Eric Fink Owned Company Details

What does Global Blood Therapeutics Inc do?

Who are the key executives at Global Blood Therapeutics Inc?

Eric Fink is the Chief Human Resources Officer of Global Blood Therapeutics Inc. Other key executives at Global Blood Therapeutics Inc include Chief Financial Officer Jeffrey S Farrow , See Remarks Nazila Habibizad , and Chief Human Resources Officer Carrie Krehlik .

Global Blood Therapeutics Inc (GBT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Global Blood Therapeutics Inc Insider Transactions

No Available Data

Eric Fink Mailing Address

Above is the net worth, insider trading, and ownership report for Eric Fink. You might contact Eric Fink via mailing address: C/o Global Blood Therapeutics, Inc. 171 Oyster Point Blvd., Suite 300 South San Francisco Ca 94080.